The effects of 12 weeks of resistance training combined with 5:2 intermittent fasting or continuous energy restriction on body composition, strength, compliance and gut microbiome.

Not Applicable

Completed

• Conditions: Excess adiposity; Loss of lean body mass; Diet and Nutrition - Other diet and nutrition disorders; Diet and Nutrition - Obesity

• Registration Number: ACTRN12620000920998
• Lead Sponsor: Swinburne University of Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2019-11-01
• Study Start: 2020-09-17
• Last Update Posted: 21 September 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

1. Aged between 18-45 years
2. BMI of 22.0-35.0
3. Body fat percentage >18% for males and >25% for females as assessed by dual x-ray absorptiometry
4. No structured resistance training program in the previous 6 months
5. Weight stable for 3 months prior to the study (<5% weight loss or weight gain)

Exclusion Criteria

1. Smokers
2. Have diabetes
3. Have a history of cardiovascular disease
4. Are taking dietary supplements and unwilling to cease for the duration of the study
5. Taking glucose, blood lipid lowering or weight loss medication.
6. Have a current physical condition that could be exacerbated by resistance training (as determined by GP).
7. Are pregnant/intend to become pregnant during the course of the study
8. Are menopausal/post-menopausal
9. Have a history of disordered eating
10. Have a current or previous respiratory condition likely to be exacerbated by the intervention
11. Have a current or previous gastrointestinal disorder likely to be exacerbated by the intervention
12. Have an allergy to any components of the provided supplement
13. Were unable to commit to fasting if in the 5:2 intermittent fasting group
14. Do not speak English at a level with which they are able to understand and complete the requirements of the study or
14. Any other disclosed chronic disease or condition, or taking any other medication that investigators deem would contraindicate the study intervention.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ean body mass changes as assessed by dual x-ray absorptiometry.[Baseline and post week 12.]